Even in this case, the present study provides the first evidence for such a prognostic relationship in any cancer type and, similarly to the potential of NG2/CSPG4, emphasizes that SDC2 may serve as a putative target for prevention and/or treatment of relapsing oral cavity HNSCC. This evidence concerns the gene SDC2 and head and neck squamous cell carcinoma.